Current Report · Items 7.01, 9.01 · 8-K
FOXO TECHNOLOGIES INC
Regulation FD Disclosure
Item Regulation 7.01 FD Disclosure. On July 6, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), issued a press release announcing a mid-year update to shareholders by the Company’s Chief Executive Officer, Seamus Lagan. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.…
Filed Jul 6, 2026Accepted Jul 6, 2026, 4:05 PM EDTCIK 1812360Accession 0001493152-26-032156
Company context
We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.
Current securities
Historical securities (10)
DWINNYSE · EQUITY · Historical · closed Sep 15, 2022DWIN.UNNYSE · UNIT · Historical · closed Sep 15, 2022DWIN.WSNYSE · WARRANT · Historical · closed Sep 15, 2022FOXONYSE_AMERICAN · EQUITY · Historical · closed Aug 12, 2025FOXOOTC · EQUITY · Historical · closed Jul 1, 2026FOXOOTC · EQUITY · Historical · closed Oct 19, 2026FOXODOTC · EQUITY · Historical · closed Jul 30, 2026FOXOWOTC · WARRANT · Historical · closed May 17, 2023FOXOWOTC · WARRANT · Historical · closed Oct 19, 2026FOXO.WSNYSE · WARRANT · Historical · closed Jan 24, 2023 Disclosure sections
Items 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item Regulation
7.01 FD Disclosure.
On
July 6, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), issued a press release announcing a
mid-year update to shareholders by the Company’s Chief Executive Officer, Seamus Lagan. A copy of the press release is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.
The
information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed”
for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on
Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto,
is material or that the dissemination of such information is required by Regulation FD.
Cautionary
Statement Regarding Forward-Looking Statements
This
Current Report on Form 8-K contains “forward-looking statements.” Any statements contained in this Current Report on Form
8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as “if,” “may,” “should,” “expects,” “plans,”
“anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue”
or the negative of these terms or other comparable terminology. These forward-looking statements are based on information currently available
to the Company’s management as well as estimates and assumptions made by its management and are subject to risks and uncertainties
that may cause actual results, performance or developments to differ materially from those contained in the statements. These statements
are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s or its
industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity
or performance expressed or implied by these forward-looking statements. These forward-looking statements are made as of the date of
this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such
date.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htmEX-99.1
2
ex99-1.htm
EX-99.1
Exhibit 99.1
FOXO
TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
WEST
PALM BEACH, FL, July 6, 2026 (GLOBE NEWSWIRE) - FOXO Technologies Inc. (OTC: FOXOD/FOXO) (the “Company”) announces
the following mid-year update to shareholders by the Company’s Chief Executive Officer Seamus Lagan.
FOXO
Shareholders:
As
we have reached the mid-year point of the year, I wanted to provide our shareholders with an update on achievements for the first six
months of 2026 and preview our go-forward operating and growth strategy for the remainder of the year and on a longer-term basis. Our
acquisitions in mid-2024 of both Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. (including its principal subsidiary,
Scott County Community Hospital, Inc.) and Vector BioSource, Inc. (“Vector”) in late 2025 have led to the creation of a diverse,
synergistic portfolio of healthcare-related businesses that provide both stability and future growth opportunities.
This
year, we have focused on optimizing our operating entities as well as addressing several corporate-level issues which have now been resolved.
In addition, we are actively c…
Open exhibit ↗